Pharmacist-Led Rx Intervention to Manage Hypertension Saves Lives, Money
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 7, 2023 -- A pharmacist-prescribing intervention to improve blood pressure (BP) control could provide high economic value compared with usual care, according to a study published online Nov. 3 in JAMA Network Open.
Dave L. Dixon, Pharm.D., from Virginia Commonwealth University in Richmond, and colleagues estimated the cost-effectiveness of implementing a pharmacist-prescribing intervention to improve BP control in the United States. The analysis compared the pharmacist-prescribing intervention used in The Alberta Clinical Trial in Optimizing Hypertension (or RxACTION) versus an active intervention, including a BP wallet card, education, and usual care.
The researchers found that during a 30-year time horizon, the pharmacist-prescribing intervention yielded 2,100 fewer cases of cardiovascular (CV) disease and eight fewer cases of kidney disease per 10,000 U.S. patients. The intervention was also associated with 0.34 additional life years and 0.62 additional quality-adjusted life years. The pharmacist-prescribing intervention led to cost savings of $10,162 per person due to fewer CV events, even after the cost of the visits and medication adjustments. In more conservative analyses, the intervention continued to produce benefits despite increased costs as the incremental cost-effectiveness ratio ranged from $2,093 to $24,076. A 50 percent intervention uptake at the population level was associated with $1.137 trillion in cost savings and would save an estimated 30.2 million life years over 30 years.
"The necessary tools and resources are readily available to implement pharmacist-prescribing interventions across the U.S.; however, reimbursement limitations remain a barrier," the authors write.
Several authors reported financial ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Blood Pressure Down With Self-Monitoring of BP, Self-Titration of Medications
FRIDAY, May 10, 2024 -- Blood pressure (BP) self-monitoring, together with self-titration of antihypertensive medications, is associated with a reduction in BP, according to a...
Novel Genetic Loci ID'd for Hypertension in European Ancestry
TUESDAY, May 7, 2024 -- A total of 113 novel genetic loci have been identified in the largest single-stage common variant genome-wide association study of blood pressure (BP)...
Long-Term Risk for MACE Increased for Children With Hypertension
TUESDAY, May 7, 2024 -- The long-term risk for major adverse cardiac events (MACE) is increased for children diagnosed with hypertension, according to a study published online May...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.